APA (7th ed.) Citation

Smith, E., Ottosson, F., Hellstrand, S., Ericson, U., Orho-Melander, M., Fernandez, C., & Melander, O. (2020). Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart (British Cardiac Society), 106(9), 691-697. https://doi.org/10.1136/heartjnl-2019-315485

Chicago Style (17th ed.) Citation

Smith, Einar, Filip Ottosson, Sophie Hellstrand, Ulrika Ericson, Marju Orho-Melander, Céline Fernandez, and Olle Melander. "Ergothioneine Is Associated with Reduced Mortality and Decreased Risk of Cardiovascular Disease." Heart (British Cardiac Society) 106, no. 9 (2020): 691-697. https://doi.org/10.1136/heartjnl-2019-315485.

MLA (9th ed.) Citation

Smith, Einar, et al. "Ergothioneine Is Associated with Reduced Mortality and Decreased Risk of Cardiovascular Disease." Heart (British Cardiac Society), vol. 106, no. 9, 2020, pp. 691-697, https://doi.org/10.1136/heartjnl-2019-315485.